Protalix BioTherapeutics (PLX) Gross Profit Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 75.94% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 7.76% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 16.94% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 2,488.21% |
| 10 | Protalix BioTherapeutics | 164.49 Mn | 153.70 Mn | 29.62 Mn | 1,432.49% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,432.49% |
| Dec 31, 2025 | -68.58% |
| Sep 30, 2025 | -0.59% |
| Jun 30, 2025 | 143.60% |
| Mar 31, 2025 | 68.67% |
| Dec 31, 2024 | 779.26% |
| Sep 30, 2024 | 75.79% |
| Jun 30, 2024 | -86.11% |
| Mar 31, 2024 | -82.38% |
| Dec 31, 2023 | -73.79% |
| Sep 30, 2023 | -23.31% |
| Jun 30, 2023 | 519.95% |
| Mar 31, 2023 | -35.30% |
| Dec 31, 2022 | 15.16% |
| Sep 30, 2022 | -14.87% |
| Jun 30, 2022 | 175.44% |
| Mar 31, 2022 | 53.33% |
| Dec 31, 2021 | -67.74% |
| Sep 30, 2021 | 5.42% |
| Jun 30, 2021 | -81.47% |
| Mar 31, 2021 | -64.02% |
| Dec 31, 2020 | 51.81% |
| Sep 30, 2020 | -28.26% |
| Jun 30, 2020 | -4.31% |
| Mar 31, 2020 | 117.06% |
| Dec 31, 2019 | 2,212.84% |
| Sep 30, 2019 | 980.62% |
| Jun 30, 2019 | 5,496.61% |
| Mar 31, 2019 | 415.29% |
| Dec 31, 2018 | -157.05% |
| Sep 30, 2018 | -185.89% |
| Jun 30, 2018 | -121.20% |
| Mar 31, 2018 | 103.37% |
| Dec 31, 2017 | 609.30% |
| Sep 30, 2017 | 245.97% |
| Jun 30, 2017 | 788.30% |
| Mar 31, 2017 | 413.46% |
| Sep 30, 2016 | -62.08% |
| Jun 30, 2016 | -91.54% |
| Mar 31, 2016 | -88.94% |
| Mar 31, 2015 | -57.40% |
| Mar 31, 2014 | 10.44% |
| Dec 31, 2013 | -476.55% |
| Sep 30, 2013 | -41.38% |
| Jun 30, 2013 | -92.06% |
| Mar 31, 2013 | 24.46% |
| Dec 31, 2012 | -484.35% |
| Sep 30, 2012 | 346.53% |
| Jun 30, 2012 | 562.72% |
| Mar 31, 2012 | -53.89% |
| Dec 31, 2011 | -91.04% |
| Sep 30, 2011 | -68.05% |
| Jun 30, 2011 | -874.88% |